2022 Cure CMD Request for Applications (RFA)

International Research Grants in Congenital Muscular Dystrophy
 

Collagen 6, Congenital Dystroglycanopathies, LAMA2, Congenital Laminopathy, SELENON

Application Deadline: Friday, July 22, 2022, 11:59 pm Eastern Time
 

Thanks to the tremendous efforts of the CMD patient community, Cure CMD is pleased to announce the availability of $400,000 in international research grant funding for the five primary subtypes of Congenital Muscular Dystrophy

​​

• Each CMD subtype constitutes a separate application for research project awards, independent of the other four CMD subtypes (funding award levels vary by subtype, see below)

• Applications that propose research in more than one CMD subtype are also welcome (funding award capped at $100,000)

• Applicants must be affiliated with an accredited academic institution and in good standing

• Inclusion of junior investigators in your proposed project is also encouraged

 

Cure CMD welcomes applications for meaningful research that could translate into a treatment or care optimization, propelling our mission in support of those living with congenital muscular dystrophy.